Curexo Inc (060280) - Total Assets
Based on the latest financial reports, Curexo Inc (060280) holds total assets worth ₩103.65 Billion KRW (≈ $70.24 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Curexo Inc - Total Assets Trend (2006–2024)
This chart illustrates how Curexo Inc's total assets have evolved over time, based on quarterly financial data. Also see Curexo Inc stock valuation for the company's overall valuation and market capitalisation.
Curexo Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Curexo Inc's total assets of ₩103.65 Billion consist of 85.7% current assets and 14.3% non-current assets. Review Curexo Inc (060280) financial obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩13.88 Billion | 0.0% |
| Accounts Receivable | ₩15.01 Billion | 14.6% |
| Inventory | ₩37.11 Billion | 36.2% |
| Property, Plant & Equipment | ₩7.85 Billion | 7.7% |
| Intangible Assets | ₩636.13 Million | 0.6% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2006–2024)
This chart illustrates how Curexo Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 060280 stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Curexo Inc's current assets represent 85.7% of total assets in 2024, an increase from 0.0% in 2006.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 7.3% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 25.0% in 2006.
- Asset Diversification: The largest asset category is inventory at 36.2% of total assets.
Curexo Inc Competitors by Total Assets
Key competitors of Curexo Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Seouleaguer Co. Ltd
KQ:043710
|
Korea | ₩126.21 Billion |
|
Gimat Magazacilik Sanayi ve Ticaret AS
IS:GMTAS
|
Turkey | TL5.60 Billion |
|
HYBE Co. Ltd
KO:352820
|
Korea | ₩5.66 Trillion |
|
Amorepacific Corp. (New)
KO:090430
|
Korea | ₩7.04 Trillion |
|
HLB Co. Ltd
KQ:028300
|
Korea | ₩925.44 Billion |
|
SKC Co. Ltd
KO:011790
|
Korea | ₩6.77 Trillion |
|
Eugene Technology Co.Ltd
KQ:084370
|
Korea | ₩627.82 Billion |
|
Douzone Bizon Co Ltd
KO:012510
|
Korea | ₩1.15 Trillion |
Curexo Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 11.22 | 12.71 | 11.46 |
| Quick Ratio | 6.10 | 7.37 | 5.24 |
| Cash Ratio | 0.00 | 0.76 | 0.00 |
| Working Capital | ₩81.66 Billion | ₩84.20 Billion | ₩35.66 Billion |
Curexo Inc - Advanced Valuation Insights
This section examines the relationship between Curexo Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.60 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -4.5% |
| Total Assets | ₩102.58 Billion |
| Market Capitalization | $176.32 Million USD |
Valuation Analysis
Below Book Valuation: The market values Curexo Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Curexo Inc's assets decreased by 4.5% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Curexo Inc (2006–2024)
The table below shows the annual total assets of Curexo Inc from 2006 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩102.58 Billion ≈ $69.52 Million |
-4.46% |
| 2023-12-31 | ₩107.37 Billion ≈ $72.76 Million |
+9.12% |
| 2022-12-31 | ₩98.40 Billion ≈ $66.68 Million |
+60.50% |
| 2021-12-31 | ₩61.31 Billion ≈ $41.55 Million |
+25.42% |
| 2020-12-31 | ₩48.88 Billion ≈ $33.12 Million |
+3.72% |
| 2019-12-31 | ₩47.13 Billion ≈ $31.94 Million |
-35.74% |
| 2018-12-31 | ₩73.34 Billion ≈ $49.70 Million |
-2.93% |
| 2017-12-31 | ₩75.55 Billion ≈ $51.20 Million |
-3.45% |
| 2016-12-31 | ₩78.25 Billion ≈ $53.03 Million |
+33.47% |
| 2015-12-31 | ₩58.63 Billion ≈ $39.73 Million |
+45.35% |
| 2014-12-31 | ₩40.34 Billion ≈ $27.33 Million |
+2.02% |
| 2013-12-31 | ₩39.54 Billion ≈ $26.79 Million |
-23.12% |
| 2012-12-31 | ₩51.43 Billion ≈ $34.85 Million |
-41.60% |
| 2011-12-31 | ₩88.07 Billion ≈ $59.68 Million |
+226.01% |
| 2010-12-31 | ₩27.01 Billion ≈ $18.31 Million |
-13.27% |
| 2009-12-31 | ₩31.15 Billion ≈ $21.11 Million |
-34.70% |
| 2008-12-31 | ₩47.70 Billion ≈ $32.32 Million |
+18.04% |
| 2007-12-31 | ₩40.41 Billion ≈ $27.38 Million |
+7.03% |
| 2006-12-31 | ₩37.75 Billion ≈ $25.59 Million |
-- |
About Curexo Inc
Curexo Inc. engages in the development and sale of medical devices in Korea and internationally. Its products include ROBIN, a robot system that guides needle path induring CT-guided interventional procedure; Baidy, a medical device that assists labor by increasing intrauterine pressure which helps natural childbirth; artificial joint surgical robot; and Gait rehabilitation robot. The company als… Read more